Welcome to our dedicated page for Cannabix Technol news (Ticker: BLOZF), a resource for investors and traders seeking the latest updates and insights on Cannabix Technol stock.
Cannabix Technologies Inc. (OTC: BLOZF) appears in its public news releases as a developer of marijuana and alcohol breath testing devices for workplaces, law enforcement and other safety-focused environments. The BLOZF news feed on Stock Titan aggregates these disclosures, giving investors and observers a single place to review the company’s reported milestones and product updates.
Company news frequently highlights progress on the Marijuana Breath Test (MBT)
Another recurring topic in Cannabix news is the BreathLogix autonomous alcohol screening platform. Announcements describe sales agreements with customers in sectors such as maritime shipping and oil and gas transportation, integration of BreathLogix with the cloud-based BreathLogix Connect portal, and features such as pre-access alcohol testing, real-time reporting and identity confirmation.
Readers of the BLOZF news page can review updates on regulatory milestones, such as FCC and Canadian emissions testing for the BCU and NHTSA Conforming Products List status for BreathLogix Workplace Series devices, as well as patent developments like the grant of a U.S. patent for contact-free breath analysis. For those tracking Cannabix’s progress in breath-based cannabis and alcohol detection technologies, this news stream offers a consolidated view of the company’s self-reported activities and partnerships over time.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Cannabix Technologies Inc. has announced a pilot program for its innovative Contactless Alcohol Breathalyzer (CAB) in collaboration with the Friedel Clinic in Montana. The CAB technology features wall-mounted and in-vehicle units, allowing employers to perform alcohol tests quickly and safely without contact. With high-volume drug testing, the Friedel Clinic plans to enhance workplace safety through this new technology. Current market trends show a push for alcohol detection systems in vehicles. However, the CAB is still in the preapproval phase, and no commercial sales are occurring yet.
Cannabix Technologies Inc. has partnered with the North Louisiana Criminalistics Laboratory (NLCL) to advance marijuana breathalyzer technology. This collaboration aims to enhance public safety by utilizing Cannabix's MS Breath Sampler for testing THC in breath samples. The NLCL will host this technology, enabling more efficient analysis of THC concentrations. Cannabix's approach simplifies the testing process, reducing time and costs significantly compared to traditional methods. CEO Rav Mlait expressed enthusiasm over this installation, marking a significant step in developing practical drug-screening devices for law enforcement and workplaces.
Cannabix Technologies is pioneering marijuana breathalyzer devices aimed at enhancing public safety. The company has partnered with the Warren County District Attorney’s office in Pennsylvania to pilot its breath collection units (BCU) for detecting THC in breath samples. The pilot program will see the deployment of two BCUs for potential usage over three months, targeting impaired driving detection. Cannabix's technology could revolutionize law enforcement protocols regarding cannabis consumption, aligning more closely with impairment timing and improving road safety.